About Hyperfine
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care in a healthcare facility. Our mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging.
Hyperfine was founded in 2014 by Jonathan Rothberg, PhD, a serial entrepreneur and the founder or co-founder of numerous innovative companies. With a vision to save lives by making magnetic resonance imaging (MRI) more accessible and affordable, Rothberg and a team of scientists and engineers set out to put MRI within reach of every patient regardless of location.
While the Hyperfine team retained the fundamental principles and core components of MRI, they turned nearly everything else on its head. The team designed the Swoop system for simplicity while leveraging advances in image-centric computing, deep learning, and the ten-million-fold increase in computing power since the invention of MRI technology over 40 years ago.
Hyperfine produced the first Swoop system MR brain images within a year of its founding and has since rapidly advanced image quality and functionality. In 2020, the Swoop system received initial FDA clearance. In December 2021, Hyperfine, Inc. Class A common stock began trading on the Nasdaq Global Market under the “HYPR” symbol.